Drug interaction between standardized herbal medicines by the Unified Health System and conventional medicines

Medicinal plants and phytotherapics are considered an alternative for the treatment of several diseases. The SUS has 12 phytotherapics standardized in the RENAME: artichoke, mastic, aloe vera, holy cashew, espinheira-santa, devil's claw, guaco, mint, soy isoflavone, plantago, willow and unha-de...

ver descrição completa

Detalhes bibliográficos
Autores: Rubio, Karina Taciana Santos, Nascimento, Maria Alice Pereira do, Martucci, Maria Elvira Poleti
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2022
País:Brasil
Recursos:Fundação Oswaldo Cruz (FIOCRUZ)
Repositório:Revista Fitos
Idioma:português
OAI Identifier:oai:ojs.revistafitos.far.fiocruz.br:article/1138
Acesso em linha:https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1138
Access Level:Acceso aberto
Palavra-chave:Phytotherapics
Phytotherapy
Adverse events
Drug interactions
Medicinal plants
Unified Health System
Fitoterápicos
Fitoterapia
Eventos adversos
Interações medicamentosas
Plantas Medicinais
Sistema Único de Saúde
Descrição
Resumo:Medicinal plants and phytotherapics are considered an alternative for the treatment of several diseases. The SUS has 12 phytotherapics standardized in the RENAME: artichoke, mastic, aloe vera, holy cashew, espinheira-santa, devil's claw, guaco, mint, soy isoflavone, plantago, willow and unha-de-gato. The aim of this work was to evaluate the adverse events of these phytotherapics and the possible drug interactions resulting from the use of conventional medicines concomitant with the use of these phytotherapics. The work was carried out through a review of the databases between 1995 and 2020. Medicinal plants and phytotherapics are constituted of chemical compounds, which are mostly responsible for their pharmacological actions. The complexity of these substances increases the possibility of interactions occurring when conventional drugs are used concomitantly. The interactions can be beneficial or unfavorable, since they can increase drug's effect, reduce its effectiveness, result in adverse reactions or not cause changes in the expected effect of the drug. This work emphasizes the importance of considering herbal medicines and phytotherapics with the same importance as synthetic medicines, basing clinical conduct on reliable scientific evidence, recognizing its effectiveness, but also its adverse effects and the possibility of drug interactions making, thus, its use safer and more efficient.